A remarkable response to combination chemotherapy with nivolumab and ipilimumab in a patient with primary pulmonary choriocarcinoma: a case report.

Hirokazu Iso,Kakeru Hisakane,Naoki Terashi,Erika Mikami, Satoru Matsuki, Takumi Sonokawa,Kenichiro Atsumi,Naoyuki Yoshino, Kohji Nagata,Masahiro Seike,Takashi Hirose

Translational cancer research（2023）

引用 1|浏览6

暂无评分

摘要

This is the first case of postoperative relapse PPC that has been successfully treated with the combination of chemotherapy, nivolumab, and ipilimumab. This therapy may be a promising option for advanced PPC.

查看译文

关键词

primary pulmonary choriocarcinoma,nivolumab,combination chemotherapy,ipilimumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要